Based on PFS and OS measures in newly diagnosed GBM patients, AIM2 and MAGE1 antigen expression in pre-vaccination tumors was related to longer survival, whereas HER2 and gp100 expression exhibited a trend toward prolonged PFS and OS. The gene discussed is ERBB2; the disease is glioblastoma.